Abstract
One hundred and thirty patients with soft tissue sarcoma of the head and neck were treated at the Royal Marsden Hospital between 1944 and 1988. Pathological review was possible in 103 of these cases; only pathologically reviewed cases have been analysed. The median age at presentation was 36 years, and 53% were male. Four had neurofibromatosis type I, and one previous bilateral retinoblastoma. Six had undergone previous radiotherapy, 12 to 45 years prior to developing sarcoma. The tumours were < or = 5 cm in 78% of cases and high grade in 48%. Only one patient presented with lymph node metastases and only one with distant metastases (to lung). Malignant fibrous histiocytoma was the commonest histological type, occurring in 30 cases. The overall 5 year survival was 50% (95% CI 39-60). Local tumour was the cause of death in 63% of cases and 5 year local control was only 47% (95% CI 36-58) with local recurrence occurring as late as 15 years after treatment. The only favourable independent prognostic factor for survival was the ability to perform surgery (other than biopsy), with or without radiotherapy, as opposed to radiotherapy alone (hazard ratio 0.39; P = 0.003). Only one patient had a biopsy with no further treatment. Favourable independent prognostic factors for local control at 5 years were site (tumours of the head as opposed to the neck, hazard ratio 0.42; P = 0.02) and modality of treatment (combined surgery and radiotherapy compared to either alone, hazard ratio 0.31; P = 0.002). Patients in the combined modality and single treatment modality groups were well balanced for T stage, grade and tumour site. The patients in the combined treatment group had less extensive surgery, yet their local recurrence-free survival was longer. Unlike soft tissue sarcomas at other sites, those in the head and neck region more often cause death by local recurrence. The addition of radiotherapy to surgery may result in longer local recurrence-free survival.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eeles, R., Fisher, C., A'Hern, R. et al. Head and neck sarcomas: prognostic factors and implications for treatment. Br J Cancer 68, 201–207 (1993). https://doi.org/10.1038/bjc.1993.314
Issue Date:
DOI: https://doi.org/10.1038/bjc.1993.314
This article is cited by
-
‘Triton’ Tumor of the Lower Alveolus: An Aggressive Variant of Malignant Peripheral Nerve Sheath Tumour
Indian Journal of Otolaryngology and Head & Neck Surgery (2022)
-
A Rare Case of Malignant Fibrous Histiocytoma Mimicking Benign Tumour in Maxillofacial Region
Journal of Maxillofacial and Oral Surgery (2022)
-
Primäre maligne Gefäßtumoren
Gefässchirurgie (2021)
-
Head and neck sarcomas: treatment outcomes in a tertiary referral center in Argentina
Oral and Maxillofacial Surgery (2021)
-
Disseminated and late metastatic disease from nasal pit leiomyosarcoma after radical surgical resection. Case report of a singular presentation of a rare disease
Clinical Sarcoma Research (2017)